Subscribe for the newsletter
Mobile Navigation
Subscribe for the Newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Polyphor AG
Sort By
Newest First
1 / 1
1 / 1
Sign in
Formulation
Polyphor AG: Polyphor Launches the Development of an Inhaled Formulation of its Antibiotic Murepavadin
Polyphor
PR-M10-17-NI-004
Oct 13, 2017
